Valeant Short Sellers Net 343% Profit As Eyes Turn To John Paulson

As Bill Ackman and Pershing Square Capital Management are licking their recent wounds due to well-publicized trades in Herbalife  Ltd. (NYSE:HLF) and Valeant Pharmaceuticals (NYSE:VRX), there are winners as well as losers. As short sellers count their profits, and gradually reduce their exposure, they eye hedge fund manager John Paulson, whose Paulson & Company is still long the stock, for a squeeze opportunity.

Ackman's loss puts him in the top five of all hedge fund gross dollar losses

When the dust cleared and Ackman liquidated his 27.2 million shares of Valeant Pharmaceuticals this week...